<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03281785</url>
  </required_header>
  <id_info>
    <org_study_id>MD%2f16.12.52</org_study_id>
    <nct_id>NCT03281785</nct_id>
  </id_info>
  <brief_title>Ultrasound of Diaphragmatic Musculature in Mechanically Ventilated Patients.</brief_title>
  <official_title>Ultrasound Evaluation of the Diaphragmatic Musculature in Mechanically Ventilated Patients in Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Muscle weakness and dysfunction are common problems in patients hospitalized in the intensive
      care unit. Respiratory muscle weakness during mechanical ventilation was recognized a state
      of muscular fatigue. The terminology 'ventilator-induced diaphragmatic dysfunction' (VIDD)
      originally was introduced to describe these effects of mechanical ventilation and respiratory
      muscle unloading on the diaphragm.

      Ultrasonography is becoming increasingly popular management of ICU patients. It is a simple,
      non-invasive and safe imaging technique that can be used for the assessment of distinctive
      diaphragmatic characteristics.

      Parameters such as amplitude and velocity of contraction, which can be assessed using M-mode
      ultrasound. In addition, static and dynamic (thickening fraction during inspiration)
      diaphragmatic thickness can also be measured by ultrasonography.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate the effect of different modes of mechanical ventilation
      on diaphragmatic thickness using ultrasonography and the relation between time of mechanical
      ventilation and the percentage of change of diaphragmatic thickness in head trauma patients
      subjected for mechanical ventilation (&gt;2 days) intensive care unit.

      Modes of ventilation will be used in the study are:

        -  Pressure controlled mandatory ventilation mode (P-CMV).

        -  Pressure synchronized intermittent mandatory ventilation mode (P-SIMV).

        -  Pressure support (PS) mode.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 20, 2017</start_date>
  <completion_date type="Anticipated">May 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diaphragmatic thickness</measure>
    <time_frame>for 3 weeks after initiation of mechanical ventilation</time_frame>
    <description>changes in diaphragmatic thickness from baseline to nadir</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The relation between time of mechanical ventilation and the percentage of change of diaphragmatic thickness</measure>
    <time_frame>for 3 weeks after initiation of mechanical ventilation</time_frame>
    <description>measurement of the diaphragmatic thickness as usual and calculate the percentage of change of the diaphragmatic thickness over the time of mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow coma scale (GCS)</measure>
    <time_frame>for 2 weeks after initiation of mechanical ventilation.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sequential organ failure assessment (SOFA) score</measure>
    <time_frame>for 3 weeks after admission to the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete blood picture</measure>
    <time_frame>for 3 weeks after admission to the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coagulation profile</measure>
    <time_frame>for 3 weeks after admission to the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver function</measure>
    <time_frame>for 3 weeks after admission to the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal function tests</measure>
    <time_frame>for 3 weeks after admission to the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean blood pressure</measure>
    <time_frame>for 3 weeks after admission to the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>for 3 weeks after admission to the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial Oxygen Saturation</measure>
    <time_frame>for 3 weeks after admission to the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central Venous Pressure</measure>
    <time_frame>for 3 weeks after admission to the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>temperature</measure>
    <time_frame>for 3 weeks after admission to the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mode of ventilation</measure>
    <time_frame>for 3 weeks after initiation of mechanical ventilation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tidal volume</measure>
    <time_frame>for 3 weeks after initiation of mechanical ventilation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory rate</measure>
    <time_frame>for 3 weeks after initiation of mechanical ventilation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>airway pressure</measure>
    <time_frame>for 3 weeks after initiation of mechanical ventilation</time_frame>
    <description>peak and mean airway pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>for 3 weeks after initiation of mechanical ventilation</time_frame>
    <description>Time from admission to the ICU untill discharge or death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>for 3 weeks after initiation of mechanical ventilation</time_frame>
    <description>time from initiation of mechanical ventilation till extubation or death</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">93</enrollment>
  <condition>Mechanical Ventilation</condition>
  <arm_group>
    <arm_group_label>Pressure controlled mandatory ventilation mode (P-CMV)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be ventilated using pressure controlled mandatory ventilation mode</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pressure synchronized intermittent mandatory ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be ventilated using pressure synchronized intermittent mandatory ventilation mode (P-SIMV)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pressure support mode (PS)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patents will be ventilated with pressure support mode (PS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pressure controlled mandatory ventilation mode (P-CMV)</intervention_name>
    <description>Pressure controlled mandatory ventilation mode (P-CMV)</description>
    <arm_group_label>Pressure controlled mandatory ventilation mode (P-CMV)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pressure synchronized intermittent mandatory ventilation</intervention_name>
    <description>Pressure synchronized intermittent mandatory ventilation</description>
    <arm_group_label>Pressure synchronized intermittent mandatory ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pressure support mode (PS)</intervention_name>
    <description>Pressure support mode (PS)</description>
    <arm_group_label>Pressure support mode (PS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) physical status grades I and II.

          -  Glasgow coma scale &lt; 8.

          -  Selections of patients need mechanical ventilation (&gt;2 days).

          -  Head trauma patients.

        Exclusion Criteria:

          -  History of diaphragmatic disease

          -  Neuromuscular disease

          -  Anatomical malformation of the diaphragm.

          -  Patients with chest disease

          -  Diabetic patients.

          -  Chest trauma

          -  Chest malignancy.

          -  Use of non-invasive ventilation before the start of invasive ventilation.

          -  Selection of patients of short period of mechanical ventilation (&lt; 2 days).

          -  Hemodynamic instability.

          -  Morbid obesity (body mass index &gt; 40 kg/m2).
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amal R Ali, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Professor of Anesthesia and Surgical Intensive Care</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hanaa M Elbendary, MD</last_name>
    <role>Study Director</role>
    <affiliation>Professor of Anesthesia and Surgical Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amal R Ali, MD</last_name>
    <phone>00201000221445</phone>
    <email>amal.rashad@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hanaa M Elbendary, MD</last_name>
    <phone>00201005781768</phone>
    <email>hanaa_elbendary@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mansoura University, Faculty of Medicine</name>
      <address>
        <city>Mansoura</city>
        <state>DK</state>
        <zip>050</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amal R Ali, MD</last_name>
      <phone>00201000221445</phone>
      <email>amal.rashad@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Hanaa M Elbendary, MD</last_name>
      <phone>00201005781768</phone>
      <email>hanaa_elbendary@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mohamed A Eloraby, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hatem A Saleh, M.Sec</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2017</study_first_submitted>
  <study_first_submitted_qc>September 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2017</study_first_posted>
  <last_update_submitted>September 11, 2017</last_update_submitted>
  <last_update_submitted_qc>September 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

